Summary by Futu AI
Charles F. Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 3,250 shares of common stock on June 3, 2024. The transaction was executed at a price of $460.00 per share, resulting in a total sale value of $1,495,000. Following the sale, Wagner's direct holdings in the company amount to 47,137 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.